Arkolith/Insider Trading/COAG/Form 4

Ra Capital Management, L.P.

10% OwnerHemab Therapeutics Holdings, Inc. (COAG) · full profile →Form 4 · filed Jun 17, 2026
Net Buying
Open-Market Buys
$1.7M
Open-Market Sells
$0
Net Open-Market Flow
$1.7M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 16, 2026Buy(P)62K$24.98$1.5M6.4M
Jun 15, 2026Buy(P)6K$24.89$153K6.4M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001231919-26-000665) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML